| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | 0.21 | 3e-05 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 5e-05 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0003 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0008 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.0008 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.16 | 0.001 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.098 | 0.002 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.17 | 0.002 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.098 | 0.002 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.002 |